Suppr超能文献

孕妇中各种抗磷脂抗体的患病率。

Prevalence of various antiphospholipid antibodies in pregnant women.

作者信息

Fialová L, Mikulíková L, Matous-Malbohan I, Benesová O, Zwinger A

机构信息

First Institute of Medical Chemistry and Biochemistry, First Faculty of Medicine, Charles University, Prague, Czech Republic.

出版信息

Physiol Res. 2000;49(3):299-305.

Abstract

Antiphospholipid antibodies (APAs) are characterized as a heterogeneous population of autoantibodies directed against different target antigens, predominantly anionic phospholipids or phospholipid-containing structures. The presence of APAs has been strongly associated with a variety of clinical disorders including adverse pregnancy complications such as spontaneous abortions, pregnancy-induced hypertension, preeclampsia and intrauterine growth retardation. The purpose of this study was to compare the prevalence of anticardiolipin antibodies (ACAs), which are routinely examined, with APAs directed against phosphatidylserine (APS), phosphatidylinositol (API), phosphatidylethanolamine (APE) and phosphatidylcholine (APC) in the sera of pregnant women. We examined 410 serum samples of pregnant women hospitalized in the department for pathological pregnancies. They underwent prenatal biochemical screening of fetal congenital abnormalities in the first and the second trimester of gravidity. Anticardiolipin IgG and IgM were measured using commercial ELISA kits (ImmuLisa Anti-Cardiolipin Antibody), whereas APS, APE, API and APC were determined by our modified ELISA kit. Among 410 pregnant women we found 21 patients (5.1%) positive for ACA IgG (>20 GPL) and 30 patients (7.3%) positive for ACA IgM (>10 MPL). It was found that 7.8% of pregnant women had at least one high-titer APA IgG and 9.8% high-titer APA IgM. One third of ACA IgG or IgM positive sera contained polyspecific autoantibodies reactive to at least two various phospholipids. In the group of IgG ACA positive women, 28.6% patients were positive for APS, 28.6% were positive or moderately positive for API, 23.8% for APC and 19% for APE. In the group of IgM ACA positive women, 33.3% were also positive for APS, 26.7% for APE, 26.7% for API and 23.3% for APC were present. IgG and IgM ACA negative patients exhibited a significantly lower incidence of other APA than the group of ACA positive pregnant women. It still remains to clarify if the routine examination of APA reacting with other anionic and zwitterionic antigens other than cardiolipin would improve the probability of identifying women liable to adverse pregnancy complications.

摘要

抗磷脂抗体(APAs)是一类针对不同靶抗原的异质性自身抗体,主要针对阴离子磷脂或含磷脂结构。APAs的存在与多种临床疾病密切相关,包括不良妊娠并发症,如自然流产、妊娠高血压、先兆子痫和胎儿生长受限。本研究的目的是比较常规检测的抗心磷脂抗体(ACAs)与针对孕妇血清中磷脂酰丝氨酸(APS)、磷脂酰肌醇(API)、磷脂酰乙醇胺(APE)和磷脂酰胆碱(APC)的APAs的患病率。我们检测了410例在病理妊娠科住院的孕妇血清样本。她们在妊娠的第一和第二阶段接受了胎儿先天性异常的产前生化筛查。使用商业ELISA试剂盒(ImmuLisa抗心磷脂抗体)检测抗心磷脂IgG和IgM,而APS、APE、API和APC则通过我们改良的ELISA试剂盒测定。在410例孕妇中,我们发现21例(5.1%)ACA IgG阳性(>20 GPL),30例(7.3%)ACA IgM阳性(>10 MPL)。发现7.8%的孕妇至少有一种高滴度APA IgG,9.8%有高滴度APA IgM。三分之一的ACA IgG或IgM阳性血清含有对至少两种不同磷脂有反应的多特异性自身抗体。在IgG ACA阳性女性组中,28.6%的患者APS阳性,28.6%的患者API阳性或中度阳性,23.8%的患者APC阳性,19%的患者APE阳性。在IgM ACA阳性女性组中,33.3%的患者APS也阳性,26.7%的患者APE阳性,26.7%的患者API阳性,23.3%的患者APC阳性。IgG和IgM ACA阴性患者中其他APA的发生率明显低于ACA阳性孕妇组。与除心磷脂外的其他阴离子和两性离子抗原反应的APA的常规检测是否会提高识别易发生不良妊娠并发症女性的概率仍有待阐明。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验